Fundamentals screen · refreshed after the Nov 11, 2026 close

Largest US companies: Healthcare

US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.

CriteriaCommon stockRanked by market cap844 stocks
#CompanyPriceTodayYTDP/EMkt cap
351AVRAnteris Technologies GlobalHealthcare$6.20+5.26%+24.2%—$604.2M
352ABUSArbutus BiopharmaHealthcare$3.88+1.57%−19.3%3.9×$594.8M
353FOSLFossil GroupHealthcare$9.97+26.68%+165.2%—$589.6M
354ENTXEntera BioHealthcare$3.22−0.62%+66.0%—$560.7M
355RGNXREGENXBIOHealthcare$8.47+10.14%−41.2%—$560.1M
356SRZNSurrozenHealthcare$31.88−2.33%+41.1%—$557.7M
357MYGNMyriad GeneticsHealthcare$5.72+0.88%−7.0%—$548.7M
358CBIOCrescent BiopharmaHealthcare$14.76+6.00%+24.4%—$548.1M
359RCELAvita MedicalHealthcare$17.30−1.98%+401.4%—$543.6M
360TKNOAlpha TeknovaHealthcare$8.62−1.26%+126.8%—$542.2M
361SBCSBC Medical Group Holdings IncorporatedHealthcare$5.24−0.95%+21.6%11.0×$538.9M
362OVIDOvid TherapeuticsHealthcare$2.78−0.71%+70.6%—$524.7M
363ANGOAngioDynamicsHealthcare$12.42+2.90%−3.3%—$522.3M
364DMACDiaMedica TherapeuticsHealthcare$9.66−0.10%+21.4%—$520.9M
365NGNENeurogeneHealthcare$25.10−0.71%+21.8%—$519.6M
366STTKShattuck LabsHealthcare$5.05+4.12%+38.4%—$514.3M
367BLSMBlossomHill TherapeuticsHealthcare$16.12+13.20%——$512.4M
368PHATPhathom PharmaceuticalsHealthcare$6.28+15.34%−62.1%—$510.5M
369CARLCarlsmedHealthcare$18.60+26.44%+50.6%—$509.7M
370AVTXAvalo TherapeuticsHealthcare$8.51+18.85%−53.1%—$492.1M
371EOLSEvolusHealthcare$7.42+8.96%+11.6%—$491.1M
372MDXGMiMedx GroupHealthcare$3.32−1.48%−51.0%—$484.5M
373MNPRMonopar TherapeuticsHealthcare$71.73−0.07%+9.8%—$481.5M
374OBIOOrchestra BioMed HoldingsHealthcare$6.01+4.89%+44.8%—$473.0M
375RLMDRelmada TherapeuticsHealthcare$4.43+3.75%−8.3%—$472.5M
376GYREGyre TherapeuticsHealthcare$4.26+0.71%−39.7%—$466.3M
377CTMXCytomX TherapeuticsHealthcare$2.13+7.58%−50.0%—$464.4M
378SIShoulder InnovationsHealthcare$21.92−0.05%+53.3%—$458.6M
379ASMBAssembly BiosciencesHealthcare$22.37+4.78%−34.2%—$455.5M
380ARVNArvinasHealthcare$6.91−0.14%−41.7%—$452.5M
381AQSTAquestive TherapeuticsHealthcare$3.58+1.70%−44.6%—$450.0M
382MOBIMobia MedicalHealthcare$13.47+10.41%——$448.4M
383PRTAProthenaHealthcare$8.73+1.99%−8.6%—$448.3M
384NPCENeuropaceHealthcare$12.52−1.34%−18.9%—$429.7M
385TECXTectonic TherapeuticHealthcare$21.96−0.05%+5.3%—$429.3M
386STLNStarling OncologyHealthcare$4.20−3.23%——$428.4M
387CERSCerusHealthcare$2.12+8.72%+2.9%—$428.1M
388INDPIndaptus TherapeuticsHealthcare$3.21+10.69%+10.3%—$427.7M
389CTNMContineum TherapeuticsHealthcare$10.77+1.99%−5.8%—$422.9M
390CRMDCorMedixHealthcare$5.30−1.30%−54.4%2.3×$421.2M
391MASS908 DevicesHealthcare$10.06+0.75%+91.6%—$418.3M
392PBYIPUMA BIOTECHNOLOGYHealthcare$8.08−0.74%+35.8%15.6×$417.7M
393IRDOpus GeneticsHealthcare$4.31+1.89%+114.4%—$416.6M
394MPLTMapLight TherapeuticsHealthcare$7.48+0.54%−57.4%—$415.7M
395IRLAIRulya TherapeuticsHealthcare$38.33−0.75%——$415.6M
396LYELLyell ImmunopharmaHealthcare$16.86+0.66%−45.2%—$414.5M
397TVGNTevogenHealthcare$6.00+4.90%−63.8%—$406.6M
398SPRYARS PharmaceuticalsHealthcare$3.95+10.64%−66.1%—$397.1M
399RZLTRezolute, Inc. Common Stock (NV)Healthcare$4.07+1.24%+72.5%—$393.7M
400ALECAlectorHealthcare$2.63+3.95%+68.6%9.5×$391.5M

Method & sources

Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology

Informational screen, not a recommendation.